While Mablink Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from While Mablink Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In While Mablink Bioscience Today - Breaking & Trending Today

Mablink Bioscience S.A.S.: Mablink Bioscience and Emergence Therapeutics Enter Into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy

Published: October 21, 2021

Emergence Therapeutics obtains the rights to develop a novel antibody-drug conjugate using Mablink Bioscience's proprietary PSARlink drug-linker technology. Mablink Bioscience S.A.S. a biotechnology

Source: finanznachrichten.de

Related Topics:

Nordrhein WestfalenJean Guillaume LafayKostenloser WertpapierhandelMarc LopezMablink BioscienceMarseille UniversitHeidelberg PharmaCancer Research CenterDrug AdministrationHeidelberg Pharma ResearchHeidelberg Pharma Research GmbEmergence TherapeuticsGuillaume LafayWhile Mablink BioscienceAix Marseille UniversitHeidelberg Pharma Research GmbhKurma PartnersChief Executive OfficerExecutive Officer